〔1〕LOGAN B K. Amphetamine：an update on forensic is?
sues〔J〕. J Anal Toxicol，2001，25（5）：400-404.
〔2〕HOTEHKISS A，GIBB J W. Blockade of methamphet?
amine-induced depression of tyrosine hydroxylase by GA?
BA transaminase inhibitors〔J〕. Eur J Pharmaeol，1980，66
（2）：201-205.
〔3〕NAKAYAMA M，KOYAMA T，YAMASHITA I. Long-last?
ing decrease in dopamine uptake sites following repeated
administration of methamohetamine in the rat striatum〔J〕.
Brain Res，1993，601（2）：209-212.
〔4〕SULZER D，CHEN T K，LAU Y Y，et al．Amphetamine
redistributes dopamine from synaptic vesicles to the cytosol
and promotes reverse transport〔J〕. J Neurosei，1995，15
（5）：4102-4108.
〔5〕ARES-SANTOS S，GRANADO N，ESPADAS I，et al.
Methamphetamine causes degeneration of dopamine cell
bodies and terminals of the nigrostriatal pathway evidenced
by silver staining〔J〕.Neuropsychopharmacology，2014，39
（5）:1066-1080.
〔6〕HALPIN L E，NORTHROP N A，YAMAMOTO B K. Am?
monia mediates methamphetamine- induced increases in
glutamate and excitotoxicity〔J〕. Neuropsychopharmacolo?
gy，2014 ，39（4）:1031-1038.
〔7〕PARSEGIAN A，SEE R E. Dysregulation of dopamine and
glutamate release in the prefrontal cortex and nucleus ac?
cumbens following methamphetamine self- administration
and during reinstatement in rats〔J〕. Neuropsychopharma?
cology，2014，39（4）:811-22.
〔8〕KRASNOVA I N，JUSTINOVA Z，LADENHEIM B，et al.
Methamphetamine self- administration is associated with
persistent biochemica1 alterations in striata1 and cortical
dopaminergic terminals in the rat〔J〕. PLoS One，2010，5
（1）:87-90.
〔9〕YUN J. Limonene inhibits methamphetamine-induced loco?
motor activity via regulation of 5- HT neuronal function
and dopamine release〔J〕. Phytomedicine，2014，21（6）:883-
887.
〔10〕REINER D J，YU S J，SHEN H，et al. 9-cis retinoic Ac?
id protects against methamphetamine-induced neurotoxic?
ity in nigrostriatal dopamine neurons〔J〕. Neurotox Res，
2014，25（3）:248-261.
〔11〕NESTLER E J. From neurobiology to treatment：progress
against addiction〔J〕. Nat Neurosci，2002，5：1076-1079.
〔12〕PEAKMAN M C，COLBY C，PERROTTI L I，et al. Induc?
ible，brain region-specific expression of a dominant nega?
tive mutant of c-Junin transgenic mice decreases sensitivi?
ty to cocaine〔J〕. Brain Res，2003，970（2）：73-86.
〔13〕CARATI C，SCHENK S. Role of dopamine D1-and D2-
like receptor mechanisms in drug-seeking following meth?
amphetamine self- administration in rats〔J〕. Pharmacol
Biochem Behav，2011，98（3）：449-454.
〔14〕HALL D A，POWERS J P，GULLEY J M． Blockade of
D1 dopamine receptors in the m edial prefrontal codex at?
tenuates amphetamine- and methamphetamine- induced
locomotor activity in the rat〔J〕. Brain Res，2009，1300：
51-57．
〔15〕MOHD-YUSOF A，GONZALEZ A E，VELIZ A，et al.
Role of the D1 receptor for the dopamine agonist-induced
one-trial behavioral sensitization of preweanling rats〔J〕.
Psychopharmacology（Berl），2014，17（2）：332-336.
〔16〕FRIEND D M，KEEFE K A. A role for D1 dopamine re?
ceptors in striatal methamphetamine-induced neurotoxici?
ty〔J〕. Neurosci Lett，2013，25:243-247.
〔17〕ARES-SANTOS S，GRANADO N，OLIVA I，et al. Do?
pamine D（1）receptor deletion strongly reduces neurotox?
ic effects of methamphetamine〔J〕. Neurobiol Dis，2012，
45（2）:810-820.
〔18〕KUROKAWA K，MIZUNO K，KIYOKAGE E，et al. Do?
pamine D1 receptor signaling system regulates ryanodine
receptor expression after intermittent exposure to metham?
phetamine in primary cultures of midbrain and cerebral
cortical neurons〔J〕. J Neurochem，2011，118（5）:773-783.
〔19〕CARATI C，SCHENK S. Role of dopamine D1- and D2-
like receptor mechanisms in drug-seeking following meth?
amphetamine self-administration in rats〔J〕. Pharmacol
Biochem Behav，2011，98（3）:449-454.
〔20〕GROSS N B，DUNCKER P C，MARSHALL J F. Striatal
dopamine D1 and D2 receptors: widespread influences
on methamphetamine - induced dopamine and serotonin
neurotoxicity〔J〕. Synapse，2011，65（11）:1144-1155.
〔21〕CHIANG Y C， LO Y N， CHEN J C. Crosstalk be?
tween dopamine D2 receptors and cannabinoid CB1 recep?
tors regulates CNR1 promoter activity via ERK1/2 signal?

ing〔J〕. J Neurochem，2013，127（2）:163-176.
〔22〕BEAULIEU J M，TIROTTA E，SOTNIKOVA T D，et al.
Regulation of Akt signaling by D2 and D3 dopamine re?
ceptors in vivo〔J〕. J Neurosci，2007，27（4）:881-885.
〔23〕GRANADO N，ARES-SANTOS S，OLIVA I，et al. Do?
pamine D2-receptor knockout mice are protected against
dopaminergic neurotoxicity induced by methamphet?
amine or MDMA〔J〕. Neurobiol Dis，2011，42（3）:391-403.
〔24〕YOSHIZAWA K，NARITA M，MORI T，et al. Role of do?
pamine D2 and D3 receptors in mediating the U- 50，
488H discriminative cue: comparison with methamphet?
amine and cocaine〔J〕. Addict Biol，2012 ，17（6）:949-
955.
〔25〕PATERSON N E，VOCCI F，SEVAK R J，et al. Dopamine
D3 receptors as a therapeutic target for methamphet?
amine dependence〔J〕. Am J Drug Alcohol Abuse，2014，
40（1）:1-9.
〔26〕BALADI M G，NEWMAN A H，NIELSEN S M，et al. Do?
pamine D3 receptors contribute to methamphetamine-in?
duced alterations in dopaminergic neuronal function:
Role of hyperthermia〔J〕. Eur J Pharmacol，2014，28:105-
110.
〔27〕孔晗，刘彦玲，朱杰，等. 甲基苯丙胺诱导的小鼠条件
性位置偏爱及多巴胺D3受体的调制作用〔J〕. 中国药
物依赖性杂志，2009，18（3）：l75-179.
〔28〕ZHU J，CHEN Y，ZHAO N，et al. Distinct roles of dopa?
mine D3 receptors in modulating methamphetamine- in?
duced behavioral sensitization and ultrastructural plastici?
ty in the shell of the nucleus accumbens〔J〕. J Neurosci
Res，2012，90（4）:895-904.
〔29〕ERLIJ D，ACOSTA-GARCÍA J，ROJAS-MÁRQUEZ M，
et al. Dopamine D4 receptor stimulation in GABAergic
projections of the globus pallidus to the reticular thalamic
nucleus and the substantia nigra reticulata of the rat de?
creases locomotor activity〔J〕. Neuropharmacology，2012，
62（2）:1111-1118.
〔30〕KRUZICH P J，SUCHLAND K L，GRANDY D K. Dopa?
mine D4 receptor-deficient mice，congenic on the C57BL/
6J background，are hypersensitive to amphetamine〔J〕.
Synapse，2004，53（2）:131-139.
〔31〕VOL T J，HANSON G R，FLECKENSTEIN A E. The role
of the plasmalemmal dopamine and vesicular momoamine
transporters in methamphetamine-induced popaminergic
deficits〔J〕. Neurochem，2007，101（4）：883-888.
〔32〕CZOTY P，MAKRIYANNIS A，BERGMAN J. Metham?
phetamine discrimination and in vivo micro- dialysis in
squirrel monkeys〔J〕. Psychopharmacology（Ber1），2004，
175（2）：170-178．
〔33〕HADLOCK G C，BAUCUM A J，KING J L，et al. Mecha?
nisms underlying methamphetamine- induced dopamine
transporter complex formation〔J〕. J Pharmacol Exp Ther，
2009，329（1）：169-174.
〔34〕HADLOCK G C，CHU P W，WALTERS E T，et al. Meth?
amphetamine-induced dopamine transporter complex for?
mation and dopaminergic deficits: the role of D2 receptor
activation〔J〕. J Pharmacol Exp Ther，2010，335（1）:207-
212.
〔35〕SANDOVAL V，RIDDLE E L，UGARTE Y V，et al. Meth?
aphetamine-induced rapid and reversible changes in do?
pamine transporter function：an in vitro model〔J〕. J Neu?
rosci，2001，21（4）：1413-1419．
〔36〕YUAN J，LV R，ROBERT J，et al. Dopamine transporter
dysfunction in Han Chinese people with chronic metham?
phetamine dependence after a short-term abstinence〔J〕.
Psychiatry Res，2014，221（1）:92-96.